{"transactions":[{"id":860976,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2026-03-04T23:51:51.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":156235,"price":8.1734,"value":1276971.149,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to the withholding tax provisions of the RSU agreements."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.08 to $8.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":2704496,"source":{"system":"sec-edgar","filing":"0001355537-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000135553726000002/ownership.xml","form_type":"4"}},{"id":892882,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2026-02-19T22:46:39.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\").  The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2027, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date.  Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":2860731,"source":{"system":"sec-edgar","filing":"0001193125-26-059770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000119312526059770/ownership.xml","form_type":"4"}},{"id":1071203,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-08-08T20:05:18.000Z","date":"2025-08-07","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.15,"value":41500.0,"ownership":{"direct":true},"balance_after":2335731,"source":{"system":"sec-edgar","filing":"0000950170-25-105819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025105819/ownership.xml","form_type":"4"}},{"id":1138793,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-05-22T01:23:00.000Z","date":"2025-05-21","kind":"purchase","planned":false,"acquired":true,"shares":481,"price":4.39,"value":2111.59,"ownership":{"direct":true},"balance_after":2325731,"source":{"system":"sec-edgar","filing":"0000950170-25-076012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025076012/ownership.xml","form_type":"4"}},{"id":1138792,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-05-22T01:23:00.000Z","date":"2025-05-21","kind":"purchase","planned":false,"acquired":true,"shares":9519,"price":4.4,"value":41883.6,"ownership":{"direct":true},"balance_after":2325250,"source":{"system":"sec-edgar","filing":"0000950170-25-076012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025076012/ownership.xml","form_type":"4"}},{"id":1142130,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-05-19T21:13:38.000Z","date":"2025-05-16","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":4.2236,"value":84472.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.22 to $4.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":2315731,"source":{"system":"sec-edgar","filing":"0000950170-25-074565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025074565/ownership.xml","form_type":"4"}},{"id":1219222,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-03-06T22:53:21.000Z","date":"2025-03-06","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.01,"value":25050.0,"ownership":{"direct":true},"balance_after":2295731,"source":{"system":"sec-edgar","filing":"0000950170-25-034966","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025034966/ownership.xml","form_type":"4"}},{"id":1219221,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-03-06T22:53:21.000Z","date":"2025-03-06","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.02,"value":25100.0,"ownership":{"direct":true},"balance_after":2290731,"source":{"system":"sec-edgar","filing":"0000950170-25-034966","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025034966/ownership.xml","form_type":"4"}},{"id":1221893,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-03-05T22:19:35.000Z","date":"2025-03-05","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.03,"value":25150.0,"ownership":{"direct":true},"balance_after":2285731,"source":{"system":"sec-edgar","filing":"0000950170-25-033845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025033845/ownership.xml","form_type":"4"}},{"id":1221892,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-03-05T22:19:35.000Z","date":"2025-03-05","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.01,"value":25050.0,"ownership":{"direct":true},"balance_after":2280731,"source":{"system":"sec-edgar","filing":"0000950170-25-033845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025033845/ownership.xml","form_type":"4"}},{"id":1227145,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-03-04T21:45:52.000Z","date":"2025-03-03","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.705,"value":47050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.69 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":2275731,"source":{"system":"sec-edgar","filing":"0000950170-25-032276","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025032276/ownership.xml","form_type":"4"}},{"id":1227144,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-03-04T21:45:52.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":95999,"price":4.76,"value":456955.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs."}],"balance_after":2265731,"source":{"system":"sec-edgar","filing":"0000950170-25-032276","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025032276/ownership.xml","form_type":"4"}},{"id":1238088,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-02-28T22:30:11.000Z","date":"2025-02-28","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.76,"value":47600.0,"ownership":{"direct":true},"balance_after":2361730,"source":{"system":"sec-edgar","filing":"0000950170-25-030176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025030176/ownership.xml","form_type":"4"}},{"id":1240374,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-02-27T21:13:59.000Z","date":"2025-02-27","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.76,"value":47600.0,"ownership":{"direct":true},"balance_after":2351730,"source":{"system":"sec-edgar","filing":"0000950170-25-029059","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025029059/ownership.xml","form_type":"4"}},{"id":1242598,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-02-26T21:46:41.000Z","date":"2025-02-26","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.78,"value":23900.0,"ownership":{"direct":true},"balance_after":2341730,"source":{"system":"sec-edgar","filing":"0000950170-25-027860","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025027860/ownership.xml","form_type":"4"}},{"id":1242597,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-02-26T21:46:41.000Z","date":"2025-02-26","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.75,"value":23750.0,"ownership":{"direct":true},"balance_after":2336730,"source":{"system":"sec-edgar","filing":"0000950170-25-027860","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025027860/ownership.xml","form_type":"4"}},{"id":1245543,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-02-26T00:38:24.000Z","date":"2025-02-25","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.464,"value":44640.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.445 to $4.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":2331730,"source":{"system":"sec-edgar","filing":"0000950170-25-027056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025027056/ownership.xml","form_type":"4"}},{"id":1255279,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-02-21T00:45:37.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2026, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":2321730,"source":{"system":"sec-edgar","filing":"0000950170-25-024489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025024489/ownership.xml","form_type":"4"}},{"id":1591004,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2024-03-06T21:47:54.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":24288,"price":4.1285,"value":100273.008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to the default \"same day sale\" provisions of the RSU agreements."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.12 to $4.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1871730,"source":{"system":"sec-edgar","filing":"0000950170-24-027256","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017024027256/ownership.xml","form_type":"4"}},{"id":1591003,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2024-03-06T21:47:54.000Z","date":"2024-03-04","kind":"sale","planned":false,"acquired":false,"shares":30884,"price":4.2438,"value":131065.5192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to the default \"same day sale\" provisions of the RSU agreements."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.22 to $4.275, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1896018,"source":{"system":"sec-edgar","filing":"0000950170-24-027256","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017024027256/ownership.xml","form_type":"4"}},{"id":1628390,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2024-02-21T21:52:23.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2025, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":1926902,"source":{"system":"sec-edgar","filing":"0000950170-24-018030","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017024018030/ownership.xml","form_type":"4"}},{"id":1968563,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2023-03-06T23:25:47.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":22538,"price":6.2506,"value":140876.0228,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.20 to $6.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1476902,"source":{"system":"sec-edgar","filing":"0001209191-23-016462","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919123016462/doc4.xml","form_type":"4"}},{"id":1968562,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2023-03-06T23:25:47.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":22426,"price":6.2302,"value":139718.4652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.21 to $6.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1499440,"source":{"system":"sec-edgar","filing":"0001209191-23-016462","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919123016462/doc4.xml","form_type":"4"}},{"id":2003026,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-21T23:10:08.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests with respect to 25% of the underlying shares on February 16, 2024, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":275000,"derivative":{"exercise_price":7.05,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001209191-23-011341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919123011341/doc4.xml","form_type":"4"}},{"id":2003025,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2023-02-21T23:10:08.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2024, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":1521866,"source":{"system":"sec-edgar","filing":"0001209191-23-011341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919123011341/doc4.xml","form_type":"4"}},{"id":2093117,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-07T22:58:18.000Z","date":"2022-12-06","kind":"exercise","acquired":false,"shares":75365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.12,"expiration_date":"2022-12-06","underlying":"Common Stock","underlying_shares":75635},"source":{"system":"sec-edgar","filing":"0001209191-22-060227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122060227/doc4.xml","form_type":"4"}},{"id":2093116,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-07T22:58:18.000Z","date":"2022-12-05","kind":"exercise","acquired":false,"shares":74635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option fully vested and exercisable."}],"balance_after":75365,"derivative":{"exercise_price":3.12,"expiration_date":"2022-12-06","underlying":"Common Stock","underlying_shares":74635},"source":{"system":"sec-edgar","filing":"0001209191-22-060227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122060227/doc4.xml","form_type":"4"}},{"id":2093115,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2022-12-07T22:58:18.000Z","date":"2022-12-06","kind":"sale","acquired":false,"shares":48250,"price":10.6131,"value":512082.075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 6, 2022 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.39 to $10.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1406866,"source":{"system":"sec-edgar","filing":"0001209191-22-060227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122060227/doc4.xml","form_type":"4"}},{"id":2093114,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2022-12-07T22:58:18.000Z","date":"2022-12-06","kind":"exercise","acquired":true,"shares":75365,"price":3.12,"value":235138.8,"ownership":{"direct":true},"balance_after":1455116,"source":{"system":"sec-edgar","filing":"0001209191-22-060227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122060227/doc4.xml","form_type":"4"}},{"id":2093113,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2022-12-07T22:58:18.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":47650,"price":10.6233,"value":506200.245,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 6, 2022 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.43 to $10.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1379751,"source":{"system":"sec-edgar","filing":"0001209191-22-060227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122060227/doc4.xml","form_type":"4"}},{"id":2093112,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2022-12-07T22:58:18.000Z","date":"2022-12-05","kind":"exercise","acquired":true,"shares":74635,"price":3.12,"value":232861.2,"ownership":{"direct":true},"balance_after":1427401,"source":{"system":"sec-edgar","filing":"0001209191-22-060227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122060227/doc4.xml","form_type":"4"}},{"id":2359821,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T02:27:42.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests with respect to 25% of the underlying shares on February 28, 2023, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":275000,"derivative":{"exercise_price":11.36,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001209191-22-015157","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122015157/doc4.xml","form_type":"4"}},{"id":2359820,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2022-03-03T02:27:42.000Z","date":"2022-03-02","kind":"sale","acquired":false,"shares":29588,"price":11.1513,"value":329944.6644,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.08 to $11.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1352766,"source":{"system":"sec-edgar","filing":"0001209191-22-015157","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122015157/doc4.xml","form_type":"4"}},{"id":2359819,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2022-03-03T02:27:42.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":7508,"price":11.19,"value":84014.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":1382354,"source":{"system":"sec-edgar","filing":"0001209191-22-015157","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122015157/doc4.xml","form_type":"4"}},{"id":2359818,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"President and CEO","other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2022-03-03T02:27:42.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2023, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":1389862,"source":{"system":"sec-edgar","filing":"0001209191-22-015157","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122015157/doc4.xml","form_type":"4"}},{"id":2488310,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-02T21:31:39.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":71676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in 48 equal monthly installments beginning on January 6, 2012."}],"balance_after":0,"derivative":{"exercise_price":4.88,"expiration_date":"2021-12-05","underlying":"Common Stock","underlying_shares":71676},"source":{"system":"sec-edgar","filing":"0001209191-21-067592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121067592/doc4.xml","form_type":"4"}},{"id":2488309,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-02T21:31:39.000Z","date":"2021-11-30","kind":"exercise","acquired":false,"shares":78324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in 48 equal monthly installments beginning on January 6, 2012."}],"balance_after":71676,"derivative":{"exercise_price":4.88,"expiration_date":"2021-12-05","underlying":"Common Stock","underlying_shares":78324},"source":{"system":"sec-edgar","filing":"0001209191-21-067592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121067592/doc4.xml","form_type":"4"}},{"id":2488308,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-02T21:31:39.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":46200,"price":16.0032,"value":739347.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 5, 2021 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.70 to $16.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1274862,"source":{"system":"sec-edgar","filing":"0001209191-21-067592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121067592/doc4.xml","form_type":"4"}},{"id":2488307,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-02T21:31:39.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":71676,"price":4.88,"value":349778.88,"ownership":{"direct":true},"balance_after":1321062,"source":{"system":"sec-edgar","filing":"0001209191-21-067592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121067592/doc4.xml","form_type":"4"}},{"id":2488306,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-02T21:31:39.000Z","date":"2021-11-30","kind":"sale","acquired":false,"shares":50000,"price":16.4855,"value":824275.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 5, 2021 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1249386,"source":{"system":"sec-edgar","filing":"0001209191-21-067592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121067592/doc4.xml","form_type":"4"}},{"id":2488305,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-02T21:31:39.000Z","date":"2021-11-30","kind":"exercise","acquired":true,"shares":78324,"price":4.88,"value":382221.12,"ownership":{"direct":true},"balance_after":1299386,"source":{"system":"sec-edgar","filing":"0001209191-21-067592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121067592/doc4.xml","form_type":"4"}},{"id":2799192,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-09T22:15:21.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":175000,"price":18.0003,"value":3150052.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":1221062,"source":{"system":"sec-edgar","filing":"0001209191-21-019118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121019118/doc4.xml","form_type":"4"}},{"id":2812035,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T23:41:40.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":15206,"price":18.3416,"value":278902.3696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.26 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1396062,"source":{"system":"sec-edgar","filing":"0001209191-21-017276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121017276/doc4.xml","form_type":"4"}},{"id":2812034,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T23:41:40.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":7479,"price":18.452,"value":138002.508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.32 to $18.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1411268,"source":{"system":"sec-edgar","filing":"0001209191-21-017276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121017276/doc4.xml","form_type":"4"}},{"id":2829194,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-26T22:18:13.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests with respect to 25% of the underlying shares on February 24, 2022, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":275000,"derivative":{"exercise_price":20.28,"expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001209191-21-014878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121014878/doc4.xml","form_type":"4"}},{"id":2829193,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-26T22:18:13.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":115000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":1418747,"source":{"system":"sec-edgar","filing":"0001209191-21-014878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121014878/doc4.xml","form_type":"4"}},{"id":2944128,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-15T21:24:34.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":46663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested in 48 equal monthly installments from the date of grant."}],"balance_after":0,"derivative":{"exercise_price":8.75,"expiration_date":"2020-12-15","underlying":"Common Stock","underlying_shares":46663},"source":{"system":"sec-edgar","filing":"0001209191-20-063474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120063474/doc4.xml","form_type":"4"}},{"id":2944127,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-15T21:24:34.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":61520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested in 48 equal monthly installments from the date of grant."}],"balance_after":46663,"derivative":{"exercise_price":8.75,"expiration_date":"2020-12-15","underlying":"Common Stock","underlying_shares":61520},"source":{"system":"sec-edgar","filing":"0001209191-20-063474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120063474/doc4.xml","form_type":"4"}},{"id":2944126,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-15T21:24:34.000Z","date":"2020-12-11","kind":"exercise","acquired":false,"shares":41817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested in 48 equal monthly installments from the date of grant."}],"balance_after":108183,"derivative":{"exercise_price":8.75,"expiration_date":"2020-12-15","underlying":"Common Stock","underlying_shares":41817},"source":{"system":"sec-edgar","filing":"0001209191-20-063474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120063474/doc4.xml","form_type":"4"}},{"id":2944125,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-15T21:24:34.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":39150,"price":12.9973,"value":508844.295,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 15, 2020 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.85 to $13.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4."}],"balance_after":1303747,"source":{"system":"sec-edgar","filing":"0001209191-20-063474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120063474/doc4.xml","form_type":"4"}},{"id":2944124,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-15T21:24:34.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":46663,"price":8.75,"value":408301.25,"ownership":{"direct":true},"balance_after":1342897,"source":{"system":"sec-edgar","filing":"0001209191-20-063474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120063474/doc4.xml","form_type":"4"}},{"id":2944123,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-15T21:24:34.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":51049,"price":13.1894,"value":673305.6806,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 15, 2020 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.15 to $13.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1296234,"source":{"system":"sec-edgar","filing":"0001209191-20-063474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120063474/doc4.xml","form_type":"4"}},{"id":2944122,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-15T21:24:34.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":61520,"price":8.75,"value":538300.0,"ownership":{"direct":true},"balance_after":1347283,"source":{"system":"sec-edgar","filing":"0001209191-20-063474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120063474/doc4.xml","form_type":"4"}},{"id":2944121,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-15T21:24:34.000Z","date":"2020-12-11","kind":"sale","acquired":false,"shares":35053,"price":12.8765,"value":451359.9545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 15, 2020 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1285763,"source":{"system":"sec-edgar","filing":"0001209191-20-063474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120063474/doc4.xml","form_type":"4"}},{"id":2944120,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-15T21:24:34.000Z","date":"2020-12-11","kind":"exercise","acquired":true,"shares":41817,"price":8.75,"value":365898.75,"ownership":{"direct":true},"balance_after":1320816,"source":{"system":"sec-edgar","filing":"0001209191-20-063474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120063474/doc4.xml","form_type":"4"}},{"id":3226806,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-04T22:02:17.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":5152,"price":10.9752,"value":56544.2304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.80 to $11.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1278999,"source":{"system":"sec-edgar","filing":"0001209191-20-016204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120016204/doc4.xml","form_type":"4"}},{"id":3226805,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-04T22:02:17.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":10428,"price":10.5688,"value":110211.4464,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.14 to $10.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1284151,"source":{"system":"sec-edgar","filing":"0001209191-20-016204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120016204/doc4.xml","form_type":"4"}},{"id":3240823,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-28T23:03:39.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests with respect to 25% of the underlying shares on February 26, 2021, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":140000,"derivative":{"exercise_price":11.32,"expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001209191-20-014127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120014127/doc4.xml","form_type":"4"}},{"id":3240822,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-28T23:03:39.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2021, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":1294579,"source":{"system":"sec-edgar","filing":"0001209191-20-014127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120014127/doc4.xml","form_type":"4"}},{"id":3317715,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-06T22:26:23.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":9467,"price":16.0022,"value":151492.8274,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to a written election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.81 to $16.185, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1234579,"source":{"system":"sec-edgar","filing":"0001209191-20-002031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120002031/doc4.xml","form_type":"4"}},{"id":3342134,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-13T21:21:59.000Z","date":"2019-12-12","kind":"exercise","acquired":false,"shares":85801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in 48 equal monthly installments from the date of grant."}],"balance_after":0,"derivative":{"exercise_price":10.65,"expiration_date":"2019-12-16","underlying":"Common Stock","underlying_shares":85801},"source":{"system":"sec-edgar","filing":"0001209191-19-060380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119060380/doc4.xml","form_type":"4"}},{"id":3342133,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-13T21:21:59.000Z","date":"2019-12-11","kind":"exercise","acquired":false,"shares":89199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in 48 equal monthly installments from the date of grant."}],"balance_after":85801,"derivative":{"exercise_price":10.65,"expiration_date":"2019-12-16","underlying":"Common Stock","underlying_shares":89199},"source":{"system":"sec-edgar","filing":"0001209191-19-060380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119060380/doc4.xml","form_type":"4"}},{"id":3342132,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-13T21:21:59.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":70036,"price":16.982,"value":1189351.352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 16, 2019 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.72 to $17.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1244046,"source":{"system":"sec-edgar","filing":"0001209191-19-060380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119060380/doc4.xml","form_type":"4"}},{"id":3342131,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-13T21:21:59.000Z","date":"2019-12-12","kind":"exercise","acquired":true,"shares":85801,"price":10.65,"value":913780.65,"ownership":{"direct":true},"balance_after":1314082,"source":{"system":"sec-edgar","filing":"0001209191-19-060380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119060380/doc4.xml","form_type":"4"}},{"id":3342130,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-13T21:21:59.000Z","date":"2019-12-11","kind":"sale","acquired":false,"shares":72373,"price":16.9176,"value":1224377.4648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 16, 2019 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.55 to $17.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1228281,"source":{"system":"sec-edgar","filing":"0001209191-19-060380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119060380/doc4.xml","form_type":"4"}},{"id":3342129,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-13T21:21:59.000Z","date":"2019-12-11","kind":"exercise","acquired":true,"shares":89199,"price":10.65,"value":949969.35,"ownership":{"direct":true},"balance_after":1300654,"source":{"system":"sec-edgar","filing":"0001209191-19-060380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119060380/doc4.xml","form_type":"4"}},{"id":3516631,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-05-21T21:02:19.000Z","date":"2019-05-21","kind":"exercise","acquired":false,"shares":79019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests each month with respect to 2.0833% of the aggregate option share total."}],"balance_after":0,"derivative":{"exercise_price":12.55,"expiration_date":"2019-05-21","underlying":"Common Stock","underlying_shares":79019},"source":{"system":"sec-edgar","filing":"0001209191-19-031781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/doc4.xml","form_type":"4"}},{"id":3516630,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-05-21T21:02:19.000Z","date":"2019-05-20","kind":"exercise","acquired":false,"shares":73608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests each month with respect to 2.0833% of the aggregate option share total."}],"balance_after":79019,"derivative":{"exercise_price":12.55,"expiration_date":"2019-05-21","underlying":"Common Stock","underlying_shares":73608},"source":{"system":"sec-edgar","filing":"0001209191-19-031781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/doc4.xml","form_type":"4"}},{"id":3516629,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-05-21T21:02:19.000Z","date":"2019-05-17","kind":"exercise","acquired":false,"shares":97373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests each month with respect to 2.0833% of the aggregate option share total."}],"balance_after":152627,"derivative":{"exercise_price":12.55,"expiration_date":"2019-05-21","underlying":"Common Stock","underlying_shares":97373},"source":{"system":"sec-edgar","filing":"0001209191-19-031781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/doc4.xml","form_type":"4"}},{"id":3516628,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-21T21:02:19.000Z","date":"2019-05-21","kind":"sale","acquired":false,"shares":72872,"price":15.3413,"value":1117951.2136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire May 21, 2019 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.92 to $15.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4."}],"balance_after":1211455,"source":{"system":"sec-edgar","filing":"0001209191-19-031781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/doc4.xml","form_type":"4"}},{"id":3516627,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-21T21:02:19.000Z","date":"2019-05-21","kind":"exercise","acquired":true,"shares":79019,"price":12.55,"value":991688.45,"ownership":{"direct":true},"balance_after":1284327,"source":{"system":"sec-edgar","filing":"0001209191-19-031781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/doc4.xml","form_type":"4"}},{"id":3516626,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-21T21:02:19.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":67418,"price":15.1159,"value":1019083.7462,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire May 21, 2019 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.99 to $15.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4."}],"balance_after":1205308,"source":{"system":"sec-edgar","filing":"0001209191-19-031781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/doc4.xml","form_type":"4"}},{"id":3516625,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-21T21:02:19.000Z","date":"2019-05-20","kind":"exercise","acquired":true,"shares":73608,"price":12.55,"value":923780.4,"ownership":{"direct":true},"balance_after":1272726,"source":{"system":"sec-edgar","filing":"0001209191-19-031781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/doc4.xml","form_type":"4"}},{"id":3516624,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-21T21:02:19.000Z","date":"2019-05-17","kind":"sale","acquired":false,"shares":77225,"price":15.5609,"value":1201690.5025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy a portion of the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire May 21, 2019 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.38 to $16.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1199118,"source":{"system":"sec-edgar","filing":"0001209191-19-031781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/doc4.xml","form_type":"4"}},{"id":3516623,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-21T21:02:19.000Z","date":"2019-05-17","kind":"exercise","acquired":true,"shares":97373,"price":12.55,"value":1222031.15,"ownership":{"direct":true},"balance_after":1276343,"source":{"system":"sec-edgar","filing":"0001209191-19-031781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/doc4.xml","form_type":"4"}},{"id":3618171,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-04T22:10:19.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":38166,"price":19.41,"value":740802.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.15 to $20.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1178970,"source":{"system":"sec-edgar","filing":"0001209191-19-015746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119015746/doc4.xml","form_type":"4"}},{"id":3618170,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-04T22:10:19.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":6500,"price":20.219,"value":131423.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.18 to $20.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1217136,"source":{"system":"sec-edgar","filing":"0001209191-19-015746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119015746/doc4.xml","form_type":"4"}},{"id":3622827,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-01T21:22:32.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in forty-eight (48) equal monthly installments from the date of grant, provided the Reporting Person remains continuously employed by the Issuer through each vesting date."}],"balance_after":140000,"derivative":{"exercise_price":20.62,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001209191-19-014978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119014978/doc4.xml","form_type":"4"}},{"id":3622826,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-01T21:22:32.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2020, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":1223636,"source":{"system":"sec-edgar","filing":"0001209191-19-014978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119014978/doc4.xml","form_type":"4"}},{"id":3703335,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-04T21:31:44.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":4447,"price":26.041,"value":115804.327,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4."}],"balance_after":1163636,"source":{"system":"sec-edgar","filing":"0001209191-19-001979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119001979/doc4.xml","form_type":"4"}},{"id":3703334,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-04T21:31:44.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":3056,"price":26.934,"value":82310.304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.87 to $27.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4."}],"balance_after":1168083,"source":{"system":"sec-edgar","filing":"0001209191-19-001979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119001979/doc4.xml","form_type":"4"}},{"id":3703333,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-04T21:31:44.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":7733,"price":26.322,"value":203548.026,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.87 to $26.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1171139,"source":{"system":"sec-edgar","filing":"0001209191-19-001979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119001979/doc4.xml","form_type":"4"}},{"id":3703332,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-04T21:31:44.000Z","date":"2018-12-24","kind":"gift","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift to a charitable organization."}],"balance_after":1178872,"source":{"system":"sec-edgar","filing":"0001209191-19-001979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119001979/doc4.xml","form_type":"4"}},{"id":4019401,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-02T22:36:28.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in forty-eight (48) equal monthly installments beginning on February 28, 2018, provided the Reporting Person remains continuously employed by the Issuer through each  vesting date."}],"balance_after":140000,"derivative":{"exercise_price":18.85,"expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001209191-18-015887","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118015887/doc4.xml","form_type":"4"}},{"id":4019400,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-02T22:36:28.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":60966,"price":18.7154,"value":1141003.0764,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs as reflected in this Form 4. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The Reporting The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.30 to $18.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1182872,"source":{"system":"sec-edgar","filing":"0001209191-18-015887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118015887/doc4.xml","form_type":"4"}},{"id":4019399,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-02T22:36:28.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU vests in four (4) equal annual installments beginning February 28, 2019, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":1243838,"source":{"system":"sec-edgar","filing":"0001209191-18-015887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118015887/doc4.xml","form_type":"4"}},{"id":4106920,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2018-01-04T22:13:49.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The RSUs vest in four (4) equal annual installments beginning January 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Not Applicable."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-18-002064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002064/doc4.xml","form_type":"4"}},{"id":4106919,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2018-01-04T22:13:49.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"The RSUs vest in four (4) equal annual installments beginning January 1, 2016, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Not Applicable."}],"balance_after":12500,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-002064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002064/doc4.xml","form_type":"4"}},{"id":4106918,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2018-01-04T22:13:49.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The RSUs vest in four (4) equal annual installments beginning January 1, 2015, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Not Applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-002064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002064/doc4.xml","form_type":"4"}},{"id":4106917,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-04T22:13:49.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option vested in 48 equal monthly installments beginning on February 4, 2008."}],"balance_after":0,"derivative":{"exercise_price":5.76,"expiration_date":"2018-01-03","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-18-002064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002064/doc4.xml","form_type":"4"}},{"id":4106916,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-04T22:13:49.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":21535,"price":15.296,"value":329399.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs as reflected in this Form 4. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.25 to $15.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1183838,"source":{"system":"sec-edgar","filing":"0001209191-18-002064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002064/doc4.xml","form_type":"4"}},{"id":4106915,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-04T22:13:49.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Each RSU was previously reported on Table II on a Form 4 filed with the SEC on February 17, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Starting with the January 2, 2018 vesting of the RSUs, the Issuer's method of reporting RSUs has been revised to report such grants in Table I rather than as previously reported in Table II. Accordingly, the share numbers reported in Column 5 of Table I includes unvested RSUs previously reported in Table II."}],"balance_after":1205373,"source":{"system":"sec-edgar","filing":"0001209191-18-002064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002064/doc4.xml","form_type":"4"}},{"id":4106914,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-04T22:13:49.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Each RSU was previously reported on Table II on a Form 4 filed with the SEC on December 5, 2014."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Starting with the January 2, 2018 vesting of the RSUs, the Issuer's method of reporting RSUs has been revised to report such grants in Table I rather than as previously reported in Table II. Accordingly, the share numbers reported in Column 5 of Table I includes unvested RSUs previously reported in Table II."}],"balance_after":1149123,"source":{"system":"sec-edgar","filing":"0001209191-18-002064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002064/doc4.xml","form_type":"4"}},{"id":4106913,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-04T22:13:49.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Each Restricted Stock Unit (\"RSU\") was previously reported on Table II on a Form 4 filed with the Securities and Exchange Commission (\"SEC\") on December 4, 2013."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."}],"balance_after":1124123,"source":{"system":"sec-edgar","filing":"0001209191-18-002064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002064/doc4.xml","form_type":"4"}},{"id":4106912,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-04T22:13:49.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":170225,"price":15.2958,"value":2603727.555,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire January 3, 2018 as reflected in this Form 4. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.25 to $15.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":1111623,"source":{"system":"sec-edgar","filing":"0001209191-18-002064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002064/doc4.xml","form_type":"4"}},{"id":4106911,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-04T22:13:49.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":250000,"price":5.76,"value":1440000.0,"ownership":{"direct":true},"balance_after":1281848,"source":{"system":"sec-edgar","filing":"0001209191-18-002064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002064/doc4.xml","form_type":"4"}},{"id":4106910,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-04T22:13:49.000Z","date":"2017-12-28","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift to a charitable organization."},{"field":"timeliness","element":"transactionTimeliness","label":"F1","text":"Represents a gift to a charitable organization."}],"balance_after":1031848,"source":{"system":"sec-edgar","filing":"0001209191-18-002064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002064/doc4.xml","form_type":"4"}},{"id":4402814,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-03T22:33:03.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in forty-eight (48) equal monthly installments beginning March 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each monthly vesting date."}],"balance_after":275000,"derivative":{"exercise_price":14.5,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001209191-17-017806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117017806/doc4.xml","form_type":"4"}},{"id":4402813,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2017-03-03T22:33:03.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"125,000 of the shares subject to this Restricted Stock Unit (\"RSU\") shall vest on March 1, 2018 and 75,000 of the shares subject to this RSU shall vest on March 1, 2019, provided Reporting Person remains continuously employed by the Issuer through each applicable vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive a share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects a gift of 9,000 shares as set forth on the Reporting Person's Form 5 filed on February 6, 2017."}],"balance_after":1041848,"source":{"system":"sec-edgar","filing":"0001209191-17-017806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117017806/doc4.xml","form_type":"4"}},{"id":4466021,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62782,"kind":"person","name":"Polymeropoulos Mihael Hristos","position":1,"cik":"0001355537","reported_name":"Polymeropoulos Mihael Hristos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-06T22:36:42.000Z","date":"2016-12-23","kind":"gift","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift to a charitable organization."}],"balance_after":830178,"source":{"system":"sec-edgar","filing":"0001209191-17-008087","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117008087/doc5.xml","form_type":"5"}}],"next_cursor":"2017-02-06T22:36:42.000000Z,4466021"}